Hepatitis Clinical Trials

Showing 261-280 of 2,113 trials

Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care Tool

NCT05144776

This is a cross sectional observational study to asses the performance of two novel HBV DNA testing methodologies; a) dried blood spot sampling and b) fingerstick capillary blood using the Xpert® Hepatitis B Virus viral load assay. Both novel testing methodologies will be compared with venous blood tested using a gold standard HBV DNA assay. The sensitivity and specificity of the two novel testing will be evaluated. HBV viral load tests are essential to guide antiviral treatment eligibility and effectiveness. However, many people are unable to access these tests, particularly those living in remote or limited resources settings given high cost, or unavailable infrastructure. Simple, affordable and accessible HBV viral load tests are required to increase global access to HBV testing and treatment to meet the WHO HBV elimination targets. The GeneXpert Diagnostic Systems, the most common molecular point-of-care platform globally, has the potential to provide simple and affordable HBV viral load tests. Dried Blood Spot testing is also an affordable and accessible testing methodology particularly suited to remote and resource limited settings. This proof-of-concept study will assess the feasibility and diagnostic performance of Xpert® HBV Viral Load test and Dried Blood Spot testing for the quantitation of HBV DNA from fingerstick capillary samples.

Hepatitis B

Kirby Institute268 participantsStarted Nov 2022

Sydney, New South Wales, Australia • Sydney, New South Wales, Australia • Sydney, New South Wales, Australia +3 more locations

RECRUITINGPhase 2

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

NCT06263959

A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131 tablets in patients with chronic hepatitis B

Chronic Hepatitis B

Fujian Akeylink Biotechnology Co., Ltd.45 participantsStarted Dec 2023

Beijing, China

Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care Tool

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Related Searches

Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.

Linkage to Care for Persons with Hep C Infection

Tools to Identify People At Risk or Already Infected with HIV and HCV

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

A Phase 2b Study of Icosabutate in Fatty Liver Disease

HCV Test and Treat Utilizing Simplified HCV Patient Education

The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002

A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.

Replicor Compassionate Access Program

Alcoholic Hepatitis Network Observational Study

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Burden of Hepatitis D Virus (HDV) Infection in Italy

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses